The parliamentary secretariat for consumer affairs has announced price reductions of up to 45% on 15 medicines in its drive to push costs down for consumers.

The new medicines are used to treat hay fever, glaucoma, depression,  Hepatitis A and the problems of the immune system, among other conditions.

A total of 176 medicines have had their prices reduced in the past 18 months after the intervention of the secretariat. 

Parliamentary Secretary Chris Said thanked all those who helped bring about the price cuts.

He said this exercise will continue and inspectors will also be on the lookout to ensure that medicines are sold according to the advertised prices.

Further information is available on telephone 21446446 or medicines@gov.mt

Medicine

Packet

Old price (€)

 New price

 

Reduction(€)

Alendronate

70mg tablets X 4

23.76

20.90

-2.86

Augmentin

625mg Film-coated tablets x 21

20.34

15.77

-4.57

Augmentin

1g Film-coated tablets x 14

20.34

19.98

-0.36

Havrix® Junior Monodose®

1 0.5ml ds for injection -1 prefilled syringe with 0.5ml suspension and separate needle

30.30

26.85

-3.45

Havrix® Monodose®

1 1ml ds for injection - 1 prefilled syringe with 1ml suspension for injection and separate needle

39.32

35.23

-4.09

Istin™

10mg Tablet x 28

25.25

22.43

-2.82

Klacid®

Coated tablets 500 mg x 14

28.60

24.22

-4.38

Sporal

100mg Capsule X 15

56.02

52.25

-3.77

Telfast®

120mg film-coated tablet X 30

16.31

13.38

-2.93

Trusopt

Eye drops X 5ml

18.45

15.20

-3.25

Valtrex

500mg Tablet X 10

44.00

34.99

-9.01

Wellbutrin® XR

150 mg modified release tablet X 30

35.00

19.19

-15.81

Wellbutrin® XR

300mg modified release tablet X 30

62.14

38.38

-23.76

Zinnat™

Film-coated tablets 500 mg x 14

23.22

17.80

-5.42

Zovirax®

200mg Dispersible film-coated tablets X 25

41.00

28.05

-12.95

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.